- Global Pharma News & Resources

CENTERPIECE Continues to Expand ETO Sterilization Capacity

SAN DIEGO--(BUSINESS WIRE)--CENTERPIECE, a medical device contract manufacturing and sterilization company, has announced expansion of its ethylene-oxide (ETO) sterilization capacity.

The additional processing capacity is projected to increase the company’s sterilization throughput by an estimated 50,000 pallets annually.

“When we launched ethylene-oxide sterilization operations last year, we installed the infrastructure for expansion and are prepared to quickly expand our business” said Matt Jordan, CEO of Centerpiece.

“We are further investing in a sophisticated, integrated, and expanded aeration configuration that will accelerate cycle times while leveraging our world-class emissions control system” commented Victor Saralegui, Technical Director of Sterilization for CENTERPIECE.

CENTERPIECE operates its ethylene-oxide sterilization facility in Tijuana, Mexico which is the largest medical device manufacturing center in North America. The company’s contract manufacturing facility is located nearby, offering clean room assembly and sterile-barrier packaging.

Matt Jordan also serves as the President of PiSA USA. PiSA USA is PiSA’s commercial operation, representing over 20,000 employees, 3,000,000 ft2 of pharmaceutical & medical device manufacturing, and two additional ethylene-oxide sterilization facilities.

Both CENTERPIECE and PiSA USA are headquartered in San Diego, California.

For more information about ethylene-oxide sterilization, contact

For more information about pharmaceutical and combination product outsourcing, send an email to


Matt Jordan
(858) 345-6146

Editor Details

  • Company:
    • Businesswire
Last Updated: 10-Feb-2022